Stromal cell-derived DEL-1 inhibits Tfh cell activation and inflammatory arthritis

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Hui Wang - , University of Pennsylvania (Author)
  • Xiaofei Li - , University of Pennsylvania (Author)
  • Tetsuhiro Kajikawa - , University of Pennsylvania (Author)
  • Jieun Shin - , University of Pennsylvania (Author)
  • Jong Hyung Lim - , University of Pennsylvania (Author)
  • Ioannis Kourtzelis - , University of York, Institute for Clinical Chemistry and Laboratory Medicine (Author)
  • Kosuke Nagai - , Institute of Clinical Chemistry and Laboratory Medicine (Author)
  • Jonathan M. Korostoff - , University of Pennsylvania (Author)
  • Sylvia Grossklaus - , Institute for Clinical Chemistry and Laboratory Medicine (Author)
  • Ronald Naumann - , Max Planck Institute of Molecular Cell Biology and Genetics (Author)
  • Triantafyllos Chavakis - , Institute of Clinical Chemistry and Laboratory Medicine, University of Edinburgh (Joint last author)
  • George Hajishengallis - , University of Pennsylvania (Joint last author)

Abstract

The secreted protein developmental endothelial locus 1 (DEL-1) regulates inflammatory cell recruitment and protects against inflammatory pathologies in animal models. Here, we investigated DEL-1 in inflammatory arthritis using collageninduced arthritis (CIA) and collagen Ab-induced arthritis (CAIA) models. In both models, mice with endothelium-specific overexpression of DEL-1 were protected from arthritis relative to WT controls, whereas arthritis was exacerbated in DEL-1- deficient mice. Compared with WT controls, mice with collagen VI promoter-driven overexpression of DEL-1 in mesenchymal cells were protected against CIA but not CAIA, suggesting a role for DEL-1 in the induction of the arthritogenic Ab response. Indeed, DEL-1 was expressed in perivascular stromal cells of the lymph nodes and inhibited Tfh and germinal center B cell responses. Mechanistically, DEL-1 inhibited DC-dependent induction of Tfh cells by targeting the LFA-1 integrin on T cells. Overall, DEL-1 restrained arthritis through a dual mechanism, one acting locally in the joints and associated with the antirecruitment function of endothelial cell-derived DEL-1; the other mechanism acting systemically in the lymph nodes and associated with the ability of stromal cell-derived DEL-1 to restrain Tfh responses. DEL-1 may therefore be a promising therapeutic for the treatment of inflammatory arthritis.

Details

Original languageEnglish
Article numbere150578
JournalJournal of Clinical Investigation
Volume131
Issue number19
Publication statusPublished - 1 Oct 2021
Peer-reviewedYes

External IDs

PubMed 34403362

Keywords

ASJC Scopus subject areas

Library keywords